Five centers and three facilities at the University of Maryland School of Pharmacy operate within the Department of Pharmaceutical Sciences (PSC).
A sixth center, the Center of Excellence in Regulatory Science and Innovation (M-CERSI), is a collaborative partnership co-directed by a faculty member in PSC.
Centers:
Bio- and Nano-technology Center
The Center for Nanobiotechnology at the University of Maryland School of Pharmacy strives to create a multidisciplinary research environment that provides expertise and fosters collaborations for the design, development, and translations of a clinic of nanosystems for therapeutic and diagnostic use.
Center of Excellence in Regulatory Science and Innovation (M-CERSI)
A collaborative partnership between the University of Maryland, College Park and the University of Maryland, Baltimore, the Center of Excellence in Regulatory Science and Innovation (M-CERSI) focuses on modernizing and improving the ways in which drugs and medical devices are reviewed and evaluated.
Center for Research on Complex Generics (CRCG)
A collaborative partnership between the University of Maryland, Baltimore, the University of Michigan, and the US Food and Drug Administration, the Center for Research on Complex Generics (CRCG) works to increase access to safe and effective generic drugs.
Computer Aided Drug Design Center (CADD)
The Computer-Aided Drug Design (CADD) Center at the University of Maryland School of Pharmacy facilitates collaboration between scientists in the computational, chemical, and biological sciences with the goal of transitioning discoveries in the basic sciences into novel therapeutic agents.
Mass Spectrometry Center
The Mass Spectrometry Center at the University of Maryland School of Pharmacy provides state-of-the-art expertise, methodology, and instrumentation to the School of Pharmacy and the surrounding research community.
Metallotherapeutics Research Center
The Metallotherapeutics Research Center strives to improve human health and welfare by identifying new metalloprotein drug targets, developing new metal therapeutics, and improving current metal-based medications.
Facilities:
Applied Pharmaceutics Lab (APhL)
APhL assists researchers at all levels of research and development. The lab features top-notch expertise and resources for pharmaceutical pre-formulation, formulation development, analytical methods development, and testing. There are also suites for non-clinical manufacturing research and development, and early stage GMP manufacturing.
High Throughput Screening (HTS)
The HTS Facility assists researchers in the field of drug discovery in identifying and investigating new compounds for basic research. Its faculty and staff can help researchers develop appropriate assays, screen targets against the facility’s diverse compound libraries, analyze and interpret assay results, and identify potential hits.
Nuclear Magnetic Resonance (NMR)
The NMR Facility provides support for a full range of NMR studies into the structure, dynamics, kinetics, and reaction mechanisms of small organic molecules, pharmaceuticals and biomolecules, in addition to ligand binding studies and metabolomics.